Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
This study randomizes patients undergoing PFA for A Fib to one of two standard care PFA systems. The patient will have an ICM placed to continuously monitor their heart rhythm. Follow up visits will occur until Month 36, and will include 12-lead ECG, ICM interrogation, AE updates, and QOL surveys.
The purpose of this study is to compare the efficacy of de novo catheter ablation for persistent AF with System A versus System B pulse field ablation systems to reduce the incidence of AF/AFl/AT recurrence. Single center, pilot, parallel group, two-arm, single-blind, randomized clinical trial 120 patients (60 per arm) Subjects will be randomly assigned to one of two pulse field ablation (PFA) treatment procedures (A and B) that are commonly performed in patients with persistent, symptomatic atrial fibrillation The two procedures are performed the same way but using different cardiac cathete…
Inclusion Criteria: * Symptomatic AF * Persistent AF * De novo AF ablation * Males and Females Age 18 to 89 years of age, inclusive * Willing and capable to provide informed consent * Able and willing to participate in all examinations and follow-up visits and tests associated with this clinical study Exclusion Criteria: * AF secondary to electrolyte imbalance, thyroid disease, alcohol abuse, or other reversible/non-cardiac causes * Contraindication to, or unwillingness to use, systematic anticoagulation * Left ventricular ejection fraction LVEF 30% as documented by TTE (within 3 months pri…
Pulse Field Ablation
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.